Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection.
HIV-1
SARS-CoV-2
antibody
humoral immune response
mucosal immunity
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
21 03 2022
21 03 2022
Historique:
received:
25
01
2022
revised:
15
03
2022
accepted:
19
03
2022
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
1
4
2022
Statut:
epublish
Résumé
Only limited data are available regarding the immunogenicity of the BNT162b2 mRNA vaccine in HIV-1
Identifiants
pubmed: 35337058
pii: v14030651
doi: 10.3390/v14030651
pmc: PMC8952283
pii:
doi:
Substances chimiques
RNA, Messenger
0
Vaccines, Synthetic
0
Viral Vaccines
0
mRNA Vaccines
0
BNT162 Vaccine
N38TVC63NU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Hector Foundation
ID : M2102
Organisme : German Research Foundation (DFG, graduate school GRK2505)
ID : GRK2504/401821119, project B3
Références
Arthritis Rheumatol. 2021 Dec 23;:
pubmed: 34951137
PLoS One. 2022 Feb 2;17(2):e0263468
pubmed: 35108321
Clin Infect Dis. 2021 Jul 22;:
pubmed: 34293114
J Allergy Clin Immunol. 2021 Feb;147(2):545-557.e9
pubmed: 33221383
J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):527-533
pubmed: 30179984
EClinicalMedicine. 2022 Jan;43:101226
pubmed: 34901799
PLoS One. 2021 Jun 16;16(6):e0249499
pubmed: 34133415
J Infect Dis. 2003 May 15;187(10):1534-43
pubmed: 12721933
EClinicalMedicine. 2021 Jun;36:100928
pubmed: 34109307
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Nature. 2020 Oct;586(7830):594-599
pubmed: 32998157
Vaccines (Basel). 2021 Dec 31;10(1):
pubmed: 35062724
J Clin Virol. 2020 Aug;129:104468
pubmed: 32485620
Hum Vaccin Immunother. 2012 Dec 1;8(12):1784-94
pubmed: 22906931
Vaccine. 2009 Jul 23;27(34):4731-8
pubmed: 19540026
NPJ Vaccines. 2022 Feb 28;7(1):28
pubmed: 35228535
Nat Commun. 2021 Oct 5;12(1):5839
pubmed: 34611163
J Med Virol. 2021 Sep;93(9):5257-5259
pubmed: 34009653
J Med Virol. 2022 May;94(5):2230-2236
pubmed: 35106771
Nat Commun. 2021 Jun 28;12(1):3991
pubmed: 34183681
Nat Rev Immunol. 2021 Jun;21(6):395-404
pubmed: 33927374
Lancet Reg Health Eur. 2022 Feb;13:100287
pubmed: 34961855
Clin Microbiol Infect. 2021 Dec;27(12):1851-1855
pubmed: 34438069
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288661
Infection. 2021 Oct 25;:
pubmed: 34694595
Arthritis Rheumatol. 2022 Jan;74(1):33-37
pubmed: 34196506
Pathog Immun. 2021 Jun 7;6(1):116-134
pubmed: 34136730
Lancet HIV. 2021 Jun;8(6):e334-e341
pubmed: 33933189
Int Immunopharmacol. 2022 Jan;102:108383
pubmed: 34824035
J Infect Dis. 2021 Dec 09;:
pubmed: 34888688
Sens Actuators B Chem. 2021 Oct 15;345:130394
pubmed: 34248283
Sci Rep. 2020 Nov 30;10(1):20818
pubmed: 33257702
Med (N Y). 2022 Feb 11;3(2):137-153.e3
pubmed: 35075450
Nat Med. 2021 Jul;27(7):1205-1211
pubmed: 34002089
AIDS. 2021 Nov 15;35(14):2399-2401
pubmed: 34261097
Science. 2021 Sep 17;373(6561):eabj0299
pubmed: 34529476
EBioMedicine. 2022 Jan;75:103788
pubmed: 34954658
N Engl J Med. 2021 Nov 4;385(19):1774-1785
pubmed: 34551225
Viruses. 2022 Jan 28;14(2):
pubmed: 35215870
Nat Immunol. 2019 Aug;20(8):1059-1070
pubmed: 31308541
Mucosal Immunol. 2008 Jan;1(1):23-30
pubmed: 19079157
Nat Commun. 2020 Jul 24;11(1):3774
pubmed: 32709909
Lancet HIV. 2021 Aug;8(8):e474-e485
pubmed: 34153264
J Infect. 2022 Feb;84(2):248-288
pubmed: 34560135
EClinicalMedicine. 2021 Nov;41:101158
pubmed: 34693234
J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):289-96
pubmed: 18545155
Nat Commun. 2021 Feb 19;12(1):1162
pubmed: 33608522
Viruses. 2021 Feb 04;13(2):
pubmed: 33557418
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Lancet HIV. 2021 Sep;8(9):e568-e580
pubmed: 34416193
Nat Commun. 2021 May 25;12(1):3109
pubmed: 34035301